Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

But one risk you may not be as familiar with is metabolic dysfunction–associated steatohepatitis (MASH). MASH is a type of liver inflammation and damage caused by a buildup of fat in the liver.

Opens in a new tab or window In patients with severe metabolic dysfunction-associated steatohepatitis (MASH), the investigational drug efruxifermin significantly improved fibrosis without ...

Hugh McIntyre covers music, with a focus on the global charts. Hozier scored one of the biggest hits of his career last year with the single “Too Sweet,” which shocked the music industry when ...

It’s been said that all monster movies fit into at least one of three categories. Werewolf movies play on the notion that within every man lives a beast waiting to be unleashed. Vampire films ...

Hugh McIntyre covers music, with a focus on the global charts. Hozier’s profile has been growing recently, and 2024 showed he was a true hitmaker in the rock genre. His single “Too Sweet ...

Forget the “Dinner & Diatribes,” you have to focus on securing tickets to see Hozier live. Hozier has been running his “Unreal Unearth Tour” since 2023, and he is nowhere near stopping.

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

At 10.30am on a chilly Saturday the queue outside Manze’s pie-and-mash shop on Deptford High Street stretches 50 metres down the street. The restaurant has been a fixture of the south-east ...

The third U.S. leg of Hozier's Unreal Unearth tour kicks off in Camden, New Jersey, on June 10—right after he's slated to headline Governors Ball—and will conclude in Phoenix, Arizona ...

Potential competition from GLP-1 drugs and other MASH therapies exists, but REZDIFFRA's combination use and first-mover advantage mitigate these risks. Analysts project $515M in 2025 sales ...